CY1117450T1 - CONVENIENCE ADVISORY PROVISIONS WITH IMPROVED ATTENTION - Google Patents

CONVENIENCE ADVISORY PROVISIONS WITH IMPROVED ATTENTION

Info

Publication number
CY1117450T1
CY1117450T1 CY20161100366T CY161100366T CY1117450T1 CY 1117450 T1 CY1117450 T1 CY 1117450T1 CY 20161100366 T CY20161100366 T CY 20161100366T CY 161100366 T CY161100366 T CY 161100366T CY 1117450 T1 CY1117450 T1 CY 1117450T1
Authority
CY
Cyprus
Prior art keywords
advisory
provisions
convenience
individual
medicament
Prior art date
Application number
CY20161100366T
Other languages
Greek (el)
Inventor
Niraj Vasisht
Andrew Finn
Original Assignee
Biodelivery Sciences International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07796992.1A external-priority patent/EP2054031B1/en
Application filed by Biodelivery Sciences International, Inc. filed Critical Biodelivery Sciences International, Inc.
Publication of CY1117450T1 publication Critical patent/CY1117450T1/en

Links

Abstract

Η παρούσα εφεύρεση παρέχει μεθόδους βελτιώσεως της διαβλεννογόνιας προσλήψεως ενός φαρμάκου, λ.χ., φαιντανύλης ή βουπρενορφίνης, σε ένα άτομο και σχετικές διατάξεις. Η μέθοδος περιλαμβάνει χορήγηση σε ένα άτομο μίας διατάξεως διαβλεννογόνιας χορηγήσεως φαρμάκου που περιλαμβάνει το φάρμακο. Παρέχονται επίσης διατάξεις κατάλληλες για διαβλεννογόνια χορήγηση ενός φαρμάκου σε ένα άτομο και μέθοδοι της χορηγήσεως και της χρήσεως τους. Οι διατάξεις περιλαμβάνουν ένα φάρμακο διευθετημένο εντός ενός περιβάλλοντος διαχύσεως βλεννοπροσκολλητικού πολυμερούς και ένα περιβάλλον φραγμού.The present invention provides methods for improving the transmucosal uptake of a drug, e.g., fentanyl or buprenorphine, into an individual and related devices. The method comprises administering to an individual a transmucosal drug delivery device comprising the medicament. Devices suitable for transmucosal administration of a medicament to an individual and methods of administration and use thereof are also provided. The devices comprise a medicament arranged within a mucoadhesive polymer diffusion medium and a barrier medium.

CY20161100366T 2006-07-21 2016-04-28 CONVENIENCE ADVISORY PROVISIONS WITH IMPROVED ATTENTION CY1117450T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83272506A 2006-07-21 2006-07-21
US83272606A 2006-07-21 2006-07-21
US83950406A 2006-08-23 2006-08-23
EP07796992.1A EP2054031B1 (en) 2006-07-21 2007-07-23 Transmucosal delivery devices with enhanced uptake

Publications (1)

Publication Number Publication Date
CY1117450T1 true CY1117450T1 (en) 2017-04-26

Family

ID=58606664

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100366T CY1117450T1 (en) 2006-07-21 2016-04-28 CONVENIENCE ADVISORY PROVISIONS WITH IMPROVED ATTENTION

Country Status (1)

Country Link
CY (1) CY1117450T1 (en)

Similar Documents

Publication Publication Date Title
BRPI0714712B8 (en) drug delivery device
CY1113220T1 (en) PHARMACEUTICAL PHARMACEUTICAL FORMS OF ORAL INCLUSIVE ANALYSIS
CY1124426T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SODIUM NITRIDE
CY1114139T1 (en) BUPRENORPHINE PLATE FOR DRUG REPLACEMENT TREATMENT
CY1123035T1 (en) METHODS AND COMPOSITIONS BASED ON DIPHTHERIA TOXIN-INTERLEUKIN-3 CONJUGATES
CY1121593T1 (en) TETRAHYDROCANNAVINOL PRODUCTS, COMPOSITIONS INCLUDING TETRAHYDROCANNAVINOL PRODUCTS AND METHODS FOR USING THE SAME
CY1124298T1 (en) FENFLURAMINE FOR USE IN THE THERAPEUTIC TREATMENT OF DRAVET SYNDROME
CY1119952T1 (en) Combination of one insulin and one GLP-1-agonist
CY1122143T1 (en) DRUG COMBINATIONS COMPRISING A B-RAF INHIBITOR, AN EGFR INHIBITOR, AND OPTIONALLY A PI3K-ALPHA INHIBITOR
ATE474564T1 (en) SMALL VOLUME, ORAL, TRANSMUCOSAL DOSAGE FORMS OF SUFENTANIL FOR PAIN TREATMENT
CY1111458T1 (en) DOSAGE FORMS OF GENERAL LINEAR, ANAVARASUS, ORAL FENTANYL AND METHODS OF ADMINISTRATION
CY1118350T1 (en) DOSAGE FORMS OF ORAL RECEIPT CONTAINING ACCURATE LICARVASEPIN
CY1115862T1 (en) PIRPHENIDONE TREATMENT FOR PATIENTS WITH ABSOLUTE US ADOPTION
CY1118530T1 (en) GLYX-13 FOR USE IN METHOD OF RESISTANCE TREATMENT IN DEPARTMENT THERAPY
ITMI20041317A1 (en) PHARMACEUTICAL FORMULATIONS FOR THE SAFE ADMINISTRATION OF DRUGS USED IN THE TREATMENT OF DRUG ADDICTION AND PROCEDURE FOR THEIR OBTAINING
CL2008003507A1 (en) Pharmaceutical composition comprising nicotine and a nicotinic acetylcholine receptor (nachr) opipramol desensitization inhibitor; pharmaceutical kit; medical device; and use to treat a disease or disorder of the central or peripheral nervous system.
ATE426635T1 (en) DRUG ADMINISTRATION
CY1122492T1 (en) CARRIER FOR ADMINISTRATION TO THE ORAL MUCOSA, ESPECIALLY FOR SUBLINGUAL ADMINISTRATION, OF PHYSIOLOGICALLY ACTIVE SUBSTANCES
CY1112643T1 (en) NALMEFEIN HYDROCHLORIC HYDROCHLORINE
CY1119850T1 (en) USE OF METFORMIN IN COMBINATION WITH AN INTERACTIVE GLYKINASE AND COMPOSITIONS INCLUDING METFORMIN AND ACTIVATOR
CY1114791T1 (en) PIMOBENDANI FOR USE IN THE TREATMENT OF OVERHEATIC MYCARDIOPATHY IN CATS
CY1114933T1 (en) STRONG POWERFUL MEDICINAL COMPOSITIONS CONTAINING IRESARTARTAN AND AMLODIPIN, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
CY1123398T1 (en) COMBINATION COMPOSITION
CY1113551T1 (en) Substituted nicotinamide compounds and their use in medicinal products
CY1120920T1 (en) HIGH DOSAGE COMPOSITIONS OF BUPRENORPHIN AND USE AS ANALGETIC